For specialists, one of the most difficult aspects of treating mesothelioma is deciding which treatment will be the most effective for the patient. A patient’s diagnosis can vary greatly by stage, cell type, and location of the tumor, all of which affect their prognosis. Now that immunotherapy...
Read More
Sounding more like a character in a dystopian science fiction movie, CRS-207 is actually an immunotherapy drug that has been creating a buzz in the mesothelioma community for a...
Read Post
Navigating the Bureaucracy VA benefits are a godsend for many veterans and their families. However, getting access to these benefits isn’t always easy. There are applications...
Read Post
Memorial Day is a day to take time to appreciate the freedoms we have and to celebrate those who gave their lives protecting those freedoms. Amidst the celebrations of the...
Read Post
One thing all mesothelioma patients and families wish they had was more control over their disease. It’s something not everyone has to deal with, but most are familiar...
Read Post
There is a fierce new opponent in the fight against advanced pleural mesothelioma. The novel drug, NGR-hTNF, has shown encouraging results after a Phase III clinical trial testing...
Read Post
Countries across the world have their own unfortunate legacies of asbestos exposure directly relating to how much asbestos products were proliferated during their heyday and when...
Read Post
A clinical trial that will study the efficacy of intraoperative photodynamic therapy in patients with pleural mesothelioma was announced in April. Photodynamic therapy essentially...
Read Post
A study published by the online medical publication PLOS ONE earlier this month has shown that a drug traditionally used to treat alcoholism can have a clinical benefit for...
Read Post
A promising new drug for pleural mesothelioma patients, defactinib, is now in phase II clinical trials. Defactinib holds the potential to be the first effective maintenance...
Read Post
National Asbestos Awareness Week, which lasts through April 7th, is designated to spark conversation about asbestos-related diseases such as mesothelioma. The hope is that the...
Read Post